- Title
- A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer
- Creators
- Alejandra T Perez - Memorial Cancer Institute, Hollywood, FL, United StatesBanu Arun - University of Texas MD Anderson Cancer Center, Houston, TX, United StatesMark Schactman - Statistics Collaborative, Washington, DC, United StatesCharles L Shapiro - Ohio State University Medical Center, Columbus, OH, United StatesDebu Tripathy - University of Southern California, Los Angeles, CA, United StatesMary A Tagliaferri - Bionovo, Inc., 5858 Horton Street, Suite 400, Emeryville, CA 94608, United StatesHeather S Shaw - University of North Carolina, Chapel Hill, NC, United StatesGretchen G Kimmick - Duke University Medical Center, Durham, NC, United StatesIsaac Cohen - Bionovo, Inc., 5858 Horton Street, Suite 400, Emeryville, CA 94608, United StatesEmma Shtivelman - Bionovo, Inc., 5858 Horton Street, Suite 400, Emeryville, CA 94608, United StatesKatherine A Caygill - Bionovo, Inc., 5858 Horton Street, Suite 400, Emeryville, CA 94608, United StatesDeborah Grady - University of California San Francisco, San Francisco, CA, United States
- Publication Details
- Breast cancer research and treatment, Vol.120(1), pp.111-118
- Publisher
- Springer
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 20054647
- Record Identifier
- 991031613645202976
Journal article
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer
Breast cancer research and treatment, Vol.120(1), pp.111-118
2010
PMID: 20054647
Metrics
17 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 3 Agriculture, Environment & Ecology
- 3.16 Phytochemicals
- 3.16.1739 11 Beta-Hydroxysteroid Dehydrogenase
- Web Of Science research areas
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites